Latest updates
-
In the press, Company news
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
-
Insights, Company news
Exonate at RANZCO – 8-12th November 2019, International Convention Centre Sydney (ICC)
- Awards Exonate Principal Scientist awarded Outstanding Young Investigator Award to attend meetings in Australia and New Zealand
- Company news Exonate at AusBiotech – 30th October – 1st November 2019, Melbourne Convention Center
- Company news Exonate at American Academy of Opthamology 12-15th October – San Francisco
- In the press Watch Exonate’s Dr. Catherine Beech OBE accept Top 21 #OnetoWatch award from Cofinitve
- Sunil Shah, UKBAA Angel Investor of the Year
- Exonate to present data on lead candidate EXN407 at ARVO 2019, the internationally recognised vision and ophthalmology conference